Thermo Fisher Scientific Inc. has announced an expansion of its bioprocessing capabilities across Asia, strengthening its support for the region's rapidly growing biopharmaceutical industry. The company is launching a new Bioprocess Design Center in Hyderabad, India, and expanding existing centers in Incheon, Korea, and Singapore. These facilities offer local expertise, advanced technologies, and tailored support, enabling biopharma innovators to accelerate biologics production with greater speed, efficiency, and sustainability. The expanded network provides customers with direct access to innovation, technical expertise, and expert-led training, enhancing agility and scalability from research to commercialization.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251202632179) on December 02, 2025, and is solely responsible for the information contained therein.
Comments